Effects of In Vitro Fermented Pleurotus eryngii on Intestinal Barrier Integrity and Immunomodulation in a Lipopolysaccharide-Induced Colonic ModelShow others and affiliations
2025 (English)In: Biomedicines, E-ISSN 2227-9059, Vol. 13, no 2, article id 430Article in journal (Refereed) Published
Abstract [en]
Background: This study investigates the impact of fermentation supernatants (FSs) from Pleurotus eryngii whole mushrooms (PEWS), as well as its subcomponents, digested (PEWSD) and extracted (PEWSE) forms, on intestinal barrier function and immune modulation in lipopolysaccharide (LPS) -stimulated Caco-2 cells.
Methods: Gene expression of tight junction (TJs) genes, cytokines, and key immune/metabolic receptors was assessed via qRT-PCR, while cytokine protein levels were measured using ELISA to explore post-transcriptional regulation.
Results: LPS challenge significantly downregulated TJs zonula occludens-1 (ZO-1,) occludin, and claudin-1, compromising epithelial integrity. Treatment with FS-PEWS notably restored ZO-1 and occludin expression, outperforming FS-PEWSD and FS-PEWSE, which only partially mitigated the LPS-induced damage. FS-PEWS further demonstrated potent immunomodulatory effects, upregulating anti-inflammatory IL-10 and pro-inflammatory cytokines such as IL-8 and TNF-α. The activation of key receptors like TLR-2 and mTOR suggests that FS-PEWS modulates critical immune and metabolic pathways, such as NF-kB signaling, to maintain immune homeostasis. Although mRNA expression of pro-inflammatory cytokines was altered, no corresponding protein release was detected, suggesting potential post-transcriptional regulation.
Conclusions: FS-PEWS preserves intestinal barrier integrity and modulates immune responses, particularly in low-grade inflammation, highlighting the whole food matrix's role in enhancing its bioactivity and functional food potential.
Place, publisher, year, edition, pages
MDPI, 2025. Vol. 13, no 2, article id 430
Keywords [en]
Pleurotus eryngii, gut barrier function, immune response, lipopolysaccharides, tight junctions
National Category
Immunology in the Medical Area
Identifiers
URN: urn:nbn:se:oru:diva-119480DOI: 10.3390/biomedicines13020430ISI: 001430739300001PubMedID: 40002843Scopus ID: 2-s2.0-85218876075OAI: oai:DiVA.org:oru-119480DiVA, id: diva2:1940884
Note
Funding Agencies:
This research was co-funded by EU and Greek national funds through the Operational Program Competitiveness, Entrepreneurship & Innovation, under the call RESEARCH-CREATE-INNOVATE (T1EDK-03404).
2025-02-272025-02-272025-04-28Bibliographically approved
In thesis